Insider Transactions in Q1 2025 at Immunome Inc. (IMNM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2025
|
Jack Higgins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,200
+21.73%
|
$5,200
$1.35 P/Share
|
|
Mar 26
2025
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
137,100
+14.53%
|
$959,700
$7.29 P/Share
|
|
Mar 25
2025
|
Jean Jacques Bienaime |
BUY
Open market or private purchase
|
Direct |
7,800
+19.89%
|
$54,600
$7.78 P/Share
|
|
Mar 24
2025
|
Philip Tsai Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
12,300
+26.97%
|
$98,400
$8.42 P/Share
|
|
Mar 24
2025
|
Jean Jacques Bienaime |
BUY
Open market or private purchase
|
Direct |
7,000
+22.86%
|
$56,000
$8.21 P/Share
|
|
Jan 31
2025
|
Clay B Siegall President and CEO |
BUY
Open market or private purchase
|
Direct |
150,000
+18.3%
|
$1,050,000
$7.75 P/Share
|